These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12895208)

  • 1. Oral choline decreases brain purine levels in lithium-treated subjects with rapid-cycling bipolar disorder: a double-blind trial using proton and lithium magnetic resonance spectroscopy.
    Lyoo IK; Demopulos CM; Hirashima F; Ahn KH; Renshaw PF
    Bipolar Disord; 2003 Aug; 5(4):300-6. PubMed ID: 12895208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate.
    Lyoo IK; Kong SW; Sung SM; Hirashima F; Parow A; Hennen J; Cohen BM; Renshaw PF
    Psychiatry Res; 2003 Jun; 123(2):87-100. PubMed ID: 12850248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical response of quetiapine in rapid cycling manic bipolar patients and lactate level changes in proton magnetic resonance spectroscopy.
    Kim DJ; Lyoo IK; Yoon SJ; Choi T; Lee B; Kim JE; Lee JS; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1182-8. PubMed ID: 17532107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Magnetic Resonance Spectroscopy Study of Lovastatin for Treating Bipolar Mood Disorder: A 4-Week Randomized Double-Blind, Placebo- Controlled Clinical Trial.
    Lotfi M; Shafiee S; Ghanizadeh A; Sigaroudi MO; Razeghian L
    Recent Pat Inflamm Allergy Drug Discov; 2017; 10(2):133-141. PubMed ID: 27804862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium and valproate protect against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients.
    Silverstone PH; Asghar SJ; O'Donnell T; Ulrich M; Hanstock CC
    World J Biol Psychiatry; 2004 Jan; 5(1):38-44. PubMed ID: 15048634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium does not alter the choline/creatine ratio in the temporal lobe of human volunteers as measured by proton magnetic resonance spectroscopy.
    Silverstone PH; Hanstock CC; Rotzinger S
    J Psychiatry Neurosci; 1999 May; 24(3):222-6. PubMed ID: 10354656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania.
    Machado-Vieira R; Soares JC; Lara DR; Luckenbaugh DA; Busnello JV; Marca G; Cunha A; Souza DO; Zarate CA; Kapczinski F
    J Clin Psychiatry; 2008 Aug; 69(8):1237-45. PubMed ID: 18681754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.
    Bowden CL; Grunze H; Mullen J; Brecher M; Paulsson B; Jones M; Vågerö M; Svensson K
    J Clin Psychiatry; 2005 Jan; 66(1):111-21. PubMed ID: 15669897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.
    Keck PE; Orsulak PJ; Cutler AJ; Sanchez R; Torbeyns A; Marcus RN; McQuade RD; Carson WH;
    J Affect Disord; 2009 Jan; 112(1-3):36-49. PubMed ID: 18835043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study.
    DelBello MP; Cecil KM; Adler CM; Daniels JP; Strakowski SM
    Neuropsychopharmacology; 2006 Jun; 31(6):1264-73. PubMed ID: 16292323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients.
    Stoll AL; Sachs GS; Cohen BM; Lafer B; Christensen JD; Renshaw PF
    Biol Psychiatry; 1996 Sep; 40(5):382-8. PubMed ID: 8874839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Fish Oil Monotherapy on Depression and Prefrontal Neurochemistry in Adolescents at High Risk for Bipolar I Disorder: A 12-Week Placebo-Controlled Proton Magnetic Resonance Spectroscopy Trial.
    McNamara RK; Strawn JR; Tallman MJ; Welge JA; Patino LR; Blom TJ; DelBello MP
    J Child Adolesc Psychopharmacol; 2020 Jun; 30(5):293-305. PubMed ID: 32167792
    [No Abstract]   [Full Text] [Related]  

  • 16. Inositol augmentation of lithium or valproate for bipolar depression.
    Eden Evins A; Demopulos C; Yovel I; Culhane M; Ogutha J; Grandin LD; Nierenberg AA; Sachs GS
    Bipolar Disord; 2006 Apr; 8(2):168-74. PubMed ID: 16542187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study.
    Forester BP; Finn CT; Berlow YA; Wardrop M; Renshaw PF; Moore CM
    Bipolar Disord; 2008 Sep; 10(6):691-700. PubMed ID: 18837863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
    Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
    J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
    Suppes T; Brown E; Schuh LM; Baker RW; Tohen M
    J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS; Vanderburg DG; Karayal ON; Kolluri S; Bachinsky M; Cavus I
    J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.